Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Shanghai RAAS Blood Products Co Ltd Receives No Approval for New Shares Issuance


Thursday, 17 Oct 2013 08:00pm EDT 

Shanghai RAAS Blood Products Co Ltd announced that China Securities Regulatory Commission didn't approval the Company' application for new shares issuance to acquire equity shares and to raise funds. 

Company Quote

61.09
-1.31 -2.10%
24 Apr 2014